LIDOCAINE HCL AND MENTHOL

LIDOCAINE HCL AND MENTHOL was reported 154 times

These side effects are most commonly reported by patients taking LIDOCAINE HCL AND MENTHOL:

# Side effect Count
0 DRUG INEFFECTIVE 85
1 NO ADVERSE EVENT 60
2 PAIN 6
3 RASH 6
4 THERAPEUTIC RESPONSE DECREASED 6
5 APPLICATION SITE PAIN 5
6 PRODUCT QUALITY ISSUE 5
7 SKIN BURNING SENSATION 5
8 BLISTER 4
9 PAIN IN EXTREMITY 4
10 APPLICATION SITE BURN 3
11 CONDITION AGGRAVATED 3
12 DIZZINESS 3
13 DRUG HYPERSENSITIVITY 3
14 FALL 3
15 FATIGUE 3
16 FEELING ABNORMAL 3
17 POST-ACUTE COVID-19 SYNDROME 3
18 PRODUCT DOSE OMISSION ISSUE 3
19 PRODUCT USE ISSUE 3
20 PRURITUS 3
21 ANXIETY 2
22 APPLICATION SITE RASH 2
23 ATRIAL FIBRILLATION 2
24 BLINDNESS 2
25 BURNS THIRD DEGREE 2
26 COUGH 2
27 DISCOMFORT 2
28 DRUG EFFECT LESS THAN EXPECTED 2
29 ENERGY INCREASED 2
30 INSOMNIA 2
31 MALAISE 2
32 MUSCULOSKELETAL STIFFNESS 2
33 NEURALGIA 2
34 NEUROPATHY PERIPHERAL 2
35 OFF LABEL USE 2
36 PRODUCT ADHESION ISSUE 2
37 PRODUCT PHYSICAL CONSISTENCY ISSUE 2
38 RASH ERYTHEMATOUS 2
39 SCAR 2
40 TACHYCARDIA 2
41 URTICARIA 2
42 WEIGHT INCREASED 2
43 ABDOMINAL DISCOMFORT 1
44 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1
45 ADMINISTRATION SITE NERVE DAMAGE 1
46 ANAPHYLACTIC REACTION 1
47 APPLICATION SITE IRRITATION 1
48 APPLICATION SITE VESICLES 1
49 ARTHRALGIA 1
50 ARTHRITIS 1
51 ARTHROPATHY 1
52 BACK PAIN 1
53 BLOOD CREATININE DECREASED 1
54 BLOOD GLUCOSE INCREASED 1
55 BLOOD PRESSURE DECREASED 1
56 BLOOD PRESSURE DIASTOLIC INCREASED 1
57 BLOOD PRESSURE SYSTOLIC INCREASED 1
58 BLOOD URINE PRESENT 1
59 BODY MASS INDEX INCREASED 1
60 BODY TEMPERATURE DECREASED 1
61 BRONCHITIS 1
62 BURN INFECTION 1
63 BURNING SENSATION 1
64 BURNS SECOND DEGREE 1
65 CANDIDA INFECTION 1
66 CARBON DIOXIDE INCREASED 1
67 CATARACT OPERATION 1
68 CELLULITIS 1
69 CHEMICAL BURN 1
70 CHEMICAL INJURY 1
71 CHEST DISCOMFORT 1
72 CHONDROCALCINOSIS 1
73 COAGULATION TIME PROLONGED 1
74 COMPRESSION FRACTURE 1
75 CONSTIPATION 1
76 COVID-19 1
77 DEATH 1
78 DECREASED APPETITE 1
79 DEPRESSED MOOD 1
80 DERMATITIS 1
81 DIABETIC NEPHROPATHY 1
82 DIABETIC RETINOPATHY 1
83 DIARRHOEA 1
84 DRY EYE 1
85 DYSPNOEA 1
86 ECZEMA 1
87 ERYTHEMA 1
88 ESSENTIAL HYPERTENSION 1
89 EXPIRED PRODUCT ADMINISTERED 1
90 EYE DISORDER 1
91 EYE IRRITATION 1
92 FIBROMYALGIA 1
93 FURUNCLE 1
94 GAIT DISTURBANCE 1
95 GASTROOESOPHAGEAL REFLUX DISEASE 1
96 GRANULOCYTE COUNT DECREASED 1
97 HAEMATOCRIT DECREASED 1
98 HAEMORRHAGE 1
99 HEADACHE 1
100 HEART RATE DECREASED 1
101 HEPATIC CYST 1
102 HERPES ZOSTER 1
103 HOSPITALISATION 1
104 HOT FLUSH 1
105 HYPERCHLORAEMIA 1
106 HYPERHIDROSIS 1
107 HYPERNATRAEMIA 1
108 HYPERPHAGIA 1
109 HYPERTENSION 1
110 HYPOACUSIS 1
111 HYPOAESTHESIA 1
112 HYPOKINESIA 1
113 HYPONATRAEMIA 1
114 IMMATURE GRANULOCYTE PERCENTAGE INCREASED 1
115 INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION 1
116 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1
117 INFLAMMATION 1
118 INTENTIONAL PRODUCT MISUSE 1
119 INTRAOCULAR PRESSURE INCREASED 1
120 LEUKOPENIA 1
121 LIGAMENT SPRAIN 1
122 LIMB DISCOMFORT 1
123 LIMB INJURY 1
124 LIVER DISORDER 1
125 LOSS OF CONSCIOUSNESS 1
126 LOW DENSITY LIPOPROTEIN INCREASED 1
127 LYMPHOCYTE COUNT INCREASED 1
128 LYMPHOEDEMA 1
129 MACULAR DEGENERATION 1
130 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1
131 MEMORY IMPAIRMENT 1
132 MICROALBUMINURIA 1
133 MOBILITY DECREASED 1
134 MONOCYTE COUNT INCREASED 1
135 MULTIPLE ALLERGIES 1
136 MUSCLE HYPERTROPHY 1
137 MUSCLE NECROSIS 1
138 MUSCLE STRAIN 1
139 NEPHROLITHIASIS 1
140 NERVE INJURY 1
141 NEUTROPHIL COUNT DECREASED 1
142 NICOTINE DEPENDENCE 1
143 NOCTURIA 1
144 OESOPHAGEAL NEOPLASM 1
145 OSTEOARTHRITIS 1
146 OSTEOPENIA 1
147 OSTEOPOROSIS 1
148 OXYGEN SATURATION DECREASED 1
149 PALPITATIONS 1
150 PARAESTHESIA 1
151 PELVIC PAIN 1
152 PERIPHERAL COLDNESS 1
153 PERIPHERAL SWELLING 1
154 PERIPHERAL VASCULAR DISORDER 1
155 PERIPHERAL VENOUS DISEASE 1
156 PNEUMONIA 1
157 PRODUCT ADMINISTRATION ERROR 1
158 PRODUCT DISPENSING ERROR 1
159 PRODUCT FORMULATION ISSUE 1
160 PRODUCT PACKAGING DIFFICULT TO OPEN 1
161 PRODUCT STORAGE ERROR 1
162 PRODUCT USE IN UNAPPROVED INDICATION 1
163 PROTEIN TOTAL DECREASED 1
164 PSORIATIC ARTHROPATHY 1
165 RASH PAPULAR 1
166 RASH PRURITIC 1
167 RED CELL DISTRIBUTION WIDTH INCREASED 1
168 RESPIRATORY DISORDER 1
169 SECOND DEGREE CHEMICAL BURN OF SKIN 1
170 SEIZURE 1
171 SEPSIS 1
172 SKIN EXFOLIATION 1
173 SKIN INJURY 1
174 SKIN LESION 1
175 SKIN ULCER 1
176 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1
177 SOMNOLENCE 1
178 STASIS DERMATITIS 1
179 STENOSIS 1
180 SYSTEMIC LUPUS ERYTHEMATOSUS 1
181 THERAPEUTIC PRODUCT EFFECT DECREASED 1
182 THERAPEUTIC RESPONSE SHORTENED 1
183 THERAPY INTERRUPTED 1
184 TRANSFERRIN SATURATION DECREASED 1
185 TYPE 2 DIABETES MELLITUS 1
186 TYPE V HYPERLIPIDAEMIA 1
187 URINARY TRACT INFECTION 1
188 VENOUS HYPERTENSION 1
189 VISUAL IMPAIRMENT 1
190 VITAMIN B12 INCREASED 1
191 WALKING AID USER 1
192 WHEEZING 1
193 WHITE BLOOD CELL COUNT DECREASED 1
194 WOUND INFECTION 1
195 WOUND NECROSIS 1
196 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1